"Rosetta has an outstanding group of scientists who have developed innovative genomic technologies and excellent computational tools to analyze genomic information. The acquisition of Rosetta fits Merck's objective of expanding our lead in cutting-edge science by continuing to enhance our internal research capabilities. Rosetta will be a tremendous asset in helping us more efficiently analyze gene data and intelligently select drug targets."
-Dr. Peter S. Kim
President
Merck Research Laboratories.
Rosetta Inpharmatics believes that employees who have a passion for the work they do - and are challenged by it - achieve results that often exceed expectations, and have an indelible impact on their team and the company. We foster an environment that encourages creativity, drive, teamwork, and the desire to improve the quality of human life through the advancement of drug discovery. If the same basic principles and values guide your career, we'd like to hear from you.
|